19 May 2017 - The public consultation on the revised draft ezetimibe post-market review report to the PBAC will open on Tuesday 23 May 2017 and close at 5 pm Tuesday 6 June 2017.
Interested organisations and individuals will be invited to provide a submission addressing the revised draft report to the PBAC.
To make a submission please go to the public consultation page after 23 May.